JP2002514960A - トロンビンおよびミクロフィブリルコラーゲンを含む組成物、ならびにその調製および使用の方法 - Google Patents
トロンビンおよびミクロフィブリルコラーゲンを含む組成物、ならびにその調製および使用の方法Info
- Publication number
- JP2002514960A JP2002514960A JP50479199A JP50479199A JP2002514960A JP 2002514960 A JP2002514960 A JP 2002514960A JP 50479199 A JP50479199 A JP 50479199A JP 50479199 A JP50479199 A JP 50479199A JP 2002514960 A JP2002514960 A JP 2002514960A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- collagen
- thrombin
- fibrinogen
- microfibril
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/102—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.水性媒体において、トロンビンおよびミクロフィブリルコラーゲンを含む、 止血組成物。 2.前記トロンビンがウシトロンビンである、請求項1に記載の組成物。 3.前記トロンビンが組換えトロンビンである、請求項1に記載の組成物。 4.前記トロンビンがトロンビン様化合物である、請求項1に記載の組成物。 5.前記ミクロフィブリルコラーゲンが、約3nm〜30nmの平均直径を有する、請 求項1に記載の組成物。 6.前記ミクロフィブリルコラーゲンが、約42℃〜46℃の融点を有する、請求項 5に記載の組成物。 7.カルシウムイオンをさらに含む、請求項1に記載の組成物。 8.前記カルシウムイオンが塩化カルシウムの形態で存在する、請求項7に記載 の組成物。 9.前記カルシウムイオンが、フィブリルコラーゲンをミクロフィブリルコラー ゲンに分解するに有効な濃度で存在する、請求項7に記載の組成物。 10.前記トロンビンが、少なくとも6ヶ月間2〜8℃で貯蔵された後、80%以 上の活性を保持する、請求項1に記載の組成物。 11.PEGをさらに含む、請求項1に記載の組成物。 12.前記PEGが約1,000〜8,000の平均分子量を有する、請求項1に記載の組成 物。 13.前記PEGが0.1% w/vと2% w/vとの間の濃度で存在する、請求項11に記 載の組成物。 14.前記PEGが0.1% w/vと0.3% w/vとの間の濃度で存在する、請求項13に 記載の組成物。 15.前記組成物のpHが4.5と6.6との間である、請求項1に記載の組成物。 16.前記組成物のpHが5.0と5.7との間である、請求項1に記載の組成物。 17.少なくとも1つの糖をさらに含む請求項1に記載の組成物であって、該糖 が該トロンビンを安定化するに有効な量で存在する、請求項1に記載の組成物。 18.前記糖が、マンニトール、ソルビトール、グルコース、およびスクロース からなる群から選択される、請求項1に記載の組成物。 19.少なくとも1つの生物学的に活性な薬剤をさらに含む、請求項1に記載の 組成物。 20.前記生物学的に活性な薬剤が、増殖因子、抗生物質、および治療剤からな る群から選択される、請求項19に記載の組成物。 21.フィブリノーゲンをさらに含む、請求項1に記載の組成物。 22.トロンビンを安定化させるための手段を使用しない等価な組成物の手段よ りも、非常に大きくトロンビンを安定化させる少なくとも1つの手段をさらに含 む、請求項1に記載の組成物。 23.前記手段が、pHを6.6よりも低下させる工程、糖を添加する工程、PEGを添 加する工程、トロンビンインヒビターを添加する工程、カルシウムイオン濃度を 減少させる工程、カルシウムキレート剤を添加する工程、およびタンパク質を添 加する工程からなる群から選択される、請求項22に記載の組成物。 24.前記組成物が、約200〜1000ミクロンの間隙の間を流動可能である、請求 項1に記載の組成物。 25.請求項1に記載の組成物およびフィブリノーゲンの供給源を含む、キット 。 26.前記フィブリノーゲンの供給源が水性媒体中のフィブリノーゲンである、 請求項25に記載のキット。 27.前記フィブリノーゲンの供給源が血漿である、請求項25に記載のキット 。 28.前記血漿がヒト血漿である、請求項27に記載のキット。 29.前記血漿が自己血漿である、請求項27に記載のキット。 30.請求項1に記載の組成物および血小板の懸濁物を含む、キット、 31.哺乳動物被験体の身体上または身体内の組織部位の止血を促進する方法で あって、以下の工程: (a)水性媒体においてトロンビンおよびミクロフィブリルコラーゲンを含む 止血組成物を提供する工程; (b)フィブリノーゲンを含む水性媒体を提供する工程; (c)該止血組成物と該フィブリノーゲンを含む水性媒体とを、該組織部位と 接触させる直前に混合する工程;ならびに (d)該混合物を該組織部位に接触させる工程、 を包含する、方法。 32.前記フィブリノーゲンを含む水性媒体が血漿であり、そして前記フィブリ ノーゲンを含む水性媒体を提供する工程が、前記哺乳動物被験体から該血漿を単 離する工程をさらに包含する、請求項31に記載の方法。 33.前記哺乳動物被験体がヒトであり、そして前記血漿がヒト血漿である、請 求項32に記載の方法。 34.前記ヒト血漿が、ヒト被験体由来の血液サンプルから単離される、請求項 33に記載の方法。 35.前記混合工程が、前記止血組成物および前記フィブリノーゲンを含む水性 媒体を前記組織部位に送達する間、装置で行われる、請求項31に記載の方法。 36.前記混合工程が、前記止血組成物および前記フィブリノーゲンを含む水性 媒体を前記装置から排出した後に、しかし、該止血組成物および該フィブリノー ゲンを含む水性媒体を該組織部位に接触させる前に行われる、請求項35に記載 の方法。 37.哺乳動物被験体の身体上または身体内の組織部位の止血を促進する方法で あって、以下の工程: (a)水性媒体においてトロンビンおよびミクロフィブリルコラーゲンを含む 止血組成物を提供する工程; (b)血小板を含む水性媒体を提供する工程; (c)該止血組成物と該血小板を含む水性媒体とを、該組織部位と接触させる 直前に混合する工程;ならびに (d)該混合物を該組織部位に接触させる工程、 を包含する、方法。 38.止血剤としての使用のための組成物を作製する方法であって、以下の工程 : (a)トロンビン、フィブリルコラーゲン、およびファイバー分解剤を、水性 媒体において互いに混合させる工程であって、該ファイバー分解剤は、フィブリ ルコラーゲンをミクロフィブリルコラーゲンに分解するに有効な濃度で存在する 、工程;および (b)工程(a)において形成される混合物を、安定なファイバーサイズを有 するミクロフィブリルコラーゲンを形成するに十分な時間で、かつ十分な温度で 、インキュベートする工程、 を包含する、方法。 39.前記ファイバー分解剤がカルシウムイオンである、請求項38に記載の方 法。 40.前記カルシウムイオンが10mMと200mMとの間の濃度で存在する、請求項3 9に記載の方法。 41.前記ミクロフィブリルコラーゲンのファイバーサイズが3nmと30nmとの間 の直径である、請求項39に記載の方法。 42.前記方法が、前記水性媒体にフィブリノーゲンを添加する工程をさらに包 含する、請求項38に記載の方法。 43.水性媒体においてトロンビンおよびコラーゲンを含む止血組成物であって 、該コラーゲンが、ミクロフィブリルコラーゲンと非ミクロフィブリルフィブリ ル コラーゲンとの混合物である、止血組成物。 44.前記ミクロフィブリルコラーゲンと非ミクロフィブリルフィブリルコラー ゲンとの比が少なくとも1:1(w/w)である、請求項43に記載の組成物。 45.前記ミクロフィブリルコラーゲンが、約3nm〜30nmのフィブリル直径、お よび約400nm〜500nmのフィブリル長を有し、そして前記非ミクロフィブリルフィ ブリルコラーゲンが、約30nm〜1000nmのフィブリル直径および約1000nm〜5000nm フィブリル長を有する、請求項43に記載の組成物。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87847197A | 1997-06-18 | 1997-06-18 | |
PCT/US1998/012687 WO1998057678A2 (en) | 1997-06-18 | 1998-06-17 | Compositions containing thrombin and microfibrillar collagen |
US09/099,126 US6096309A (en) | 1997-06-18 | 1998-06-17 | Compositions containing thrombin and microfibrillar nanometer collagen, and methods for preparation and use thereof |
US08/878,471 | 1998-06-17 | ||
US09/099,126 | 1998-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002514960A true JP2002514960A (ja) | 2002-05-21 |
Family
ID=26795607
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50479199A Withdrawn JP2002514960A (ja) | 1997-06-18 | 1998-06-17 | トロンビンおよびミクロフィブリルコラーゲンを含む組成物、ならびにその調製および使用の方法 |
Country Status (6)
Country | Link |
---|---|
US (2) | US6096309A (ja) |
EP (1) | EP0993311B1 (ja) |
JP (1) | JP2002514960A (ja) |
AU (1) | AU7977298A (ja) |
CA (1) | CA2295247C (ja) |
WO (1) | WO1998057678A2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010522617A (ja) * | 2007-03-26 | 2010-07-08 | バクスター・インターナショナル・インコーポレイテッド | 軟部組織増強のための注入可能な空隙の充填剤 |
JP2013508066A (ja) * | 2009-10-23 | 2013-03-07 | セウォン セロンテック カンパニー リミテッド | 血小板豊富血漿(prp)を活性化して組織再生を誘導する組成物及びその製造方法 |
JP2016502448A (ja) * | 2012-12-11 | 2016-01-28 | セウォン セロンテック カンパニー リミテッドSewon Cellontech Co.,Ltd. | コラーゲンとフィブリンとが混合された組織シーラント及びその製造方法 |
Families Citing this family (135)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
AU7977298A (en) * | 1997-06-18 | 1999-01-04 | Cohesion Technologies, Inc. | Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof |
US6428978B1 (en) * | 1998-05-08 | 2002-08-06 | Cohesion Technologies, Inc. | Methods for the production of gelatin and full-length triple helical collagen in recombinant cells |
US20020015724A1 (en) * | 1998-08-10 | 2002-02-07 | Chunlin Yang | Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
US7276235B2 (en) * | 1998-11-18 | 2007-10-02 | Zlb Behring Gmbh | Tissue glue with improved antiadhesive properties |
KR100858830B1 (ko) * | 1998-11-18 | 2008-09-17 | 체에스엘 베링 게엠베하 | 조직 접합제용의 안정화된 단백질 제제 |
US20020081732A1 (en) * | 2000-10-18 | 2002-06-27 | Bowlin Gary L. | Electroprocessing in drug delivery and cell encapsulation |
US7615373B2 (en) * | 1999-02-25 | 2009-11-10 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
US20040018226A1 (en) * | 1999-02-25 | 2004-01-29 | Wnek Gary E. | Electroprocessing of materials useful in drug delivery and cell encapsulation |
US20040116032A1 (en) * | 1999-02-25 | 2004-06-17 | Bowlin Gary L. | Electroprocessed collagen |
US6322785B1 (en) * | 1999-03-02 | 2001-11-27 | Natrex Technologies | Methods and compositions for bone graft implants |
US6472162B1 (en) * | 1999-06-04 | 2002-10-29 | Thermogenesis Corp. | Method for preparing thrombin for use in a biological glue |
US6964685B2 (en) | 1999-06-22 | 2005-11-15 | The Brigham And Women's Hospital, Inc. | Biologic replacement for fibrin clot |
US20040059416A1 (en) * | 1999-06-22 | 2004-03-25 | Murray Martha M. | Biologic replacement for fibrin clot |
US6566345B2 (en) | 2000-04-28 | 2003-05-20 | Fziomed, Inc. | Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
EP1268351A1 (en) * | 2000-03-06 | 2003-01-02 | TEI Biosciences, Inc. | Injectable bio-compatible material and methods of use |
ATE425776T1 (de) * | 2000-04-28 | 2009-04-15 | Fziomed Inc | Haemostatische zusammenstellung von polysauren und polyalkylenoxyden und deren verwendungsmethoden |
AU2001287023A1 (en) | 2000-09-01 | 2002-03-13 | Virginia Commonwealth University Intellectual Property Foundation | Plasma-derived-fibrin-based matrices and tissue |
JP2004508305A (ja) * | 2000-09-01 | 2004-03-18 | ヴァージニア コモンウェルス ユニバーシティ インテレクチュアル プロパティー ファンデーション | 電気処理されたフィブリンをベースとするマトリックスおよび組織 |
DE10046187A1 (de) * | 2000-09-13 | 2002-03-21 | Univ Schiller Jena | Verfahren zur Messung der Aktivität von Gerinnungsfaktor XIIIa |
US6548556B2 (en) | 2000-12-27 | 2003-04-15 | Healthpoint, Ltd. | Stable enzymatic wound debrider |
DE10130968B4 (de) * | 2001-06-27 | 2009-08-20 | Envisiontec Gmbh | Beschichtetes Polymermaterial, dessen Verwendung sowie Verfahren zu dessen Herstellung |
US7923431B2 (en) * | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
CA2470684A1 (en) | 2001-12-21 | 2003-07-10 | Ferrosan A/S | A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
US20030181371A1 (en) * | 2001-12-28 | 2003-09-25 | Angiotech Pharmaceuticals, Inc. | Compositions and methods of using collajolie |
US20040182795A1 (en) * | 2003-03-21 | 2004-09-23 | Randel Dorian | Apparatus and method for concentration of plasma from whole blood |
US20030205538A1 (en) | 2002-05-03 | 2003-11-06 | Randel Dorian | Methods and apparatus for isolating platelets from blood |
US7992725B2 (en) | 2002-05-03 | 2011-08-09 | Biomet Biologics, Llc | Buoy suspension fractionation system |
US6905612B2 (en) * | 2003-03-21 | 2005-06-14 | Hanuman Llc | Plasma concentrate apparatus and method |
US7832566B2 (en) | 2002-05-24 | 2010-11-16 | Biomet Biologics, Llc | Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles |
US20060278588A1 (en) | 2002-05-24 | 2006-12-14 | Woodell-May Jennifer E | Apparatus and method for separating and concentrating fluids containing multiple components |
AU2003249642A1 (en) | 2002-05-24 | 2003-12-12 | Biomet Manufacturing Corp. | Apparatus and method for separating and concentrating fluids containing multiple components |
US7845499B2 (en) | 2002-05-24 | 2010-12-07 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
US7074425B2 (en) * | 2002-09-26 | 2006-07-11 | Bonewax, Llc | Hemostatic compositions and methods |
WO2004032713A2 (en) * | 2002-10-04 | 2004-04-22 | Nanomatrix, Inc. | Sealants for skin and other tissues |
CA2509914A1 (en) | 2002-12-11 | 2004-06-24 | Ferrosan A/S | Gelatine-based materials as swabs |
AU2003303513A1 (en) * | 2002-12-30 | 2004-07-29 | Angiotech International Ag | Tissue reactive compounds and compositions and uses thereof |
KR101213460B1 (ko) * | 2003-01-20 | 2012-12-20 | 잇판자이단호진 가가쿠오요비겟세이료호겐쿠쇼 | 지혈용 재료 |
US20040243044A1 (en) * | 2003-06-02 | 2004-12-02 | Penegor Stephen A. | Hemostatic wound dressing |
US20050033157A1 (en) * | 2003-07-25 | 2005-02-10 | Klein Dean A. | Multi-modality marking material and method |
US7927626B2 (en) | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
CA2536041A1 (en) * | 2003-11-10 | 2005-05-26 | Angiotech International Ag | Medical implants and fibrosis-inducing agents |
US20050208095A1 (en) * | 2003-11-20 | 2005-09-22 | Angiotech International Ag | Polymer compositions and methods for their use |
US20050125033A1 (en) * | 2003-12-04 | 2005-06-09 | Mcnally-Heintzelman Karen M. | Wound closure apparatus |
US20050125015A1 (en) * | 2003-12-04 | 2005-06-09 | Mcnally-Heintzelman Karen M. | Tissue-handling apparatus, system and method |
WO2005072700A2 (en) | 2004-01-30 | 2005-08-11 | Ferrosan A/S | Haemostatic sprays and compositions |
DE102004022606A1 (de) * | 2004-05-07 | 2005-12-15 | Envisiontec Gmbh | Verfahren zur Herstellung eines dreidimensionalen Objekts mit verbesserter Trennung ausgehärteter Materialschichten von einer Bauebene |
WO2005110722A1 (de) | 2004-05-10 | 2005-11-24 | Envisiontec Gmbh | Verfahren zur herstellung eines dreidimensionalen objekts mit auflösungsverbesserung mittels pixel-shift |
DE102004022961B4 (de) * | 2004-05-10 | 2008-11-20 | Envisiontec Gmbh | Verfahren zur Herstellung eines dreidimensionalen Objekts mit Auflösungsverbesserung mittels Pixel-Shift |
JP4767253B2 (ja) * | 2004-06-22 | 2011-09-07 | ザイモジェネティクス, インコーポレイテッド | トロンビン組成物 |
CN101001649B (zh) | 2004-07-09 | 2011-08-31 | 弗罗桑医疗设备公司 | 包括透明质酸的止血组合物及其制备方法 |
US7597687B2 (en) * | 2004-10-29 | 2009-10-06 | Spinal Restoration, Inc. | Injection of fibrin sealant including an anesthetic in spinal applications |
US8124075B2 (en) * | 2004-07-16 | 2012-02-28 | Spinal Restoration, Inc. | Enhanced biological autologous tissue adhesive composition and methods of preparation and use |
US8206448B2 (en) | 2004-10-29 | 2012-06-26 | Spinal Restoration, Inc. | Injection of fibrin sealant using reconstituted components in spinal applications |
US20110213464A1 (en) * | 2004-10-29 | 2011-09-01 | Whitlock Steven I | Injection of fibrin sealant in the absence of corticosteroids in spinal applications |
EP1848473B1 (en) * | 2005-02-07 | 2013-05-22 | Hanuman LLC | Plasma concentrator device |
ES2426941T3 (es) | 2005-02-07 | 2013-10-25 | Hanuman Llc | Aparato y procedimiento de concentrados de plasma rico en plaquetas |
WO2006086201A2 (en) | 2005-02-07 | 2006-08-17 | Hanuman Llc | Platelet rich plasma concentrate apparatus and method |
US7866485B2 (en) | 2005-02-07 | 2011-01-11 | Hanuman, Llc | Apparatus and method for preparing platelet rich plasma and concentrates thereof |
US7694828B2 (en) | 2005-04-27 | 2010-04-13 | Biomet Manufacturing Corp. | Method and apparatus for producing autologous clotting components |
US20060270015A1 (en) * | 2005-05-26 | 2006-11-30 | Dan Pawlak | Thrombin purification |
EP1981435A2 (en) | 2006-01-25 | 2008-10-22 | Children's Medical Center Corporation | Methods and procedures for ligament repair |
DE102006019963B4 (de) * | 2006-04-28 | 2023-12-07 | Envisiontec Gmbh | Vorrichtung und Verfahren zur Herstellung eines dreidimensionalen Objekts durch schichtweises Verfestigen eines unter Einwirkung von elektromagnetischer Strahlung verfestigbaren Materials mittels Maskenbelichtung |
DE102006019964C5 (de) * | 2006-04-28 | 2021-08-26 | Envisiontec Gmbh | Vorrichtung und Verfahren zur Herstellung eines dreidimensionalen Objekts mittels Maskenbelichtung |
US8567609B2 (en) | 2006-05-25 | 2013-10-29 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
WO2007137653A1 (en) | 2006-05-26 | 2007-12-06 | Baxter International Inc. | Injectable fibrin composition for bone augmentation |
KR101421750B1 (ko) * | 2006-05-26 | 2014-07-22 | 박스터 헬쓰케어 에스에이 | 주입가능한 골 결함 충전제 |
US7636610B2 (en) * | 2006-07-19 | 2009-12-22 | Envisiontec Gmbh | Method and device for producing a three-dimensional object, and computer and data carrier useful therefor |
WO2008060361A2 (en) | 2006-09-28 | 2008-05-22 | Children's Medical Center Corporation | Methods and collagen products for tissue repair |
US7892474B2 (en) * | 2006-11-15 | 2011-02-22 | Envisiontec Gmbh | Continuous generative process for producing a three-dimensional object |
US8003039B2 (en) | 2007-01-17 | 2011-08-23 | 3D Systems, Inc. | Method for tilting solid image build platform for reducing air entrainment and for build release |
EP2114440A1 (en) * | 2007-01-31 | 2009-11-11 | Anders Jeppsson | Use of fibrinogen as a prophylactic treatment to prevent bleeding during and after surgery and as a biomarker to identify patient with an increased risk for excessive bleeding and blood transfusion |
AU2014200027B2 (en) * | 2007-03-26 | 2015-10-29 | Baxter Healthcare Sa | Injectable void filler for soft tissue augmentation |
JP5479319B2 (ja) | 2007-04-12 | 2014-04-23 | バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー | ブイ式懸濁液分画システム |
US8328024B2 (en) | 2007-04-12 | 2012-12-11 | Hanuman, Llc | Buoy suspension fractionation system |
US8092837B2 (en) * | 2007-04-27 | 2012-01-10 | Biomet Manufacturing Corp | Fibrin based glue with functionalized hydrophilic polymer protein binding agent |
DK2011631T3 (da) | 2007-07-04 | 2012-06-25 | Envisiontec Gmbh | Fremgangsmåde og indretning til fremstilling af et tre-dimensionelt objekt |
DK2052693T4 (da) * | 2007-10-26 | 2021-03-15 | Envisiontec Gmbh | Proces og fri-formfabrikationssystem til at fremstille en tredimensionel genstand |
WO2009108890A1 (en) | 2008-02-27 | 2009-09-03 | Biomet Biologics, Llc | Methods and compositions for delivering interleukin-1 receptor antagonist |
CA2716872C (en) | 2008-02-29 | 2015-02-10 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
WO2009111338A1 (en) | 2008-02-29 | 2009-09-11 | Biomet Manufacturing Corp. | A system and process for separating a material |
CN102056619A (zh) | 2008-04-18 | 2011-05-11 | 科尔普兰特有限公司 | 产生和使用原胶原的方法 |
US8012077B2 (en) | 2008-05-23 | 2011-09-06 | Biomet Biologics, Llc | Blood separating device |
US20100086529A1 (en) * | 2008-10-08 | 2010-04-08 | Mohammad Syed F | Methods of making concentrated fibrinogen- and platelet-containing compositions |
US8187475B2 (en) | 2009-03-06 | 2012-05-29 | Biomet Biologics, Llc | Method and apparatus for producing autologous thrombin |
US8313954B2 (en) | 2009-04-03 | 2012-11-20 | Biomet Biologics, Llc | All-in-one means of separating blood components |
US9011800B2 (en) | 2009-07-16 | 2015-04-21 | Biomet Biologics, Llc | Method and apparatus for separating biological materials |
US8372330B2 (en) * | 2009-10-19 | 2013-02-12 | Global Filtration Systems | Resin solidification substrate and assembly |
US8591391B2 (en) | 2010-04-12 | 2013-11-26 | Biomet Biologics, Llc | Method and apparatus for separating a material |
AU2011260260B2 (en) | 2010-06-01 | 2015-09-03 | Baxter Healthcare S.A. | Process for making dry and stable hemostatic compositions |
EP2575775B1 (en) | 2010-06-01 | 2018-04-04 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
CA2801120C (en) | 2010-06-01 | 2019-08-20 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
US20120065666A1 (en) * | 2010-09-10 | 2012-03-15 | E. I. Du Pont De Nemours And Company | Seal-less device for dispensing microliter quantities of a material into a site |
US9447169B2 (en) * | 2011-03-04 | 2016-09-20 | Orthovita, Inc. | Flowable collagen-based hemostat and methods of use |
WO2012146655A1 (en) | 2011-04-27 | 2012-11-01 | Biom'up | Hemostatic compositions |
US20130072903A1 (en) * | 2011-09-20 | 2013-03-21 | John Chapman | Adipose Tissue Graft for Wound Healing |
US9597425B2 (en) * | 2011-10-18 | 2017-03-21 | St. Teresa Medical, Inc. | Method of forming a hemostatic product |
WO2013116744A1 (en) | 2012-02-01 | 2013-08-08 | Children's Medical Center Corporation | Biomaterial for articular cartilage maintenance and treatment of arthritis |
RU2657955C2 (ru) | 2012-03-06 | 2018-06-18 | Ферросан Медикал Дивайсиз А/С | Контейнер под давлением, содержащий гемостатическую пасту |
BR112014030962A2 (pt) | 2012-06-12 | 2017-06-27 | Ferrosan Medical Devices As | métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático |
US9642956B2 (en) | 2012-08-27 | 2017-05-09 | Biomet Biologics, Llc | Apparatus and method for separating and concentrating fluids containing multiple components |
US10016527B2 (en) | 2012-10-23 | 2018-07-10 | Orthovita, Inc. | Materials and methods for repair of cartilage defects |
US9149529B2 (en) | 2012-10-24 | 2015-10-06 | Orthovita, Inc. | Stable compositions containing thrombin and methods for preparation and use thereof |
US9446166B2 (en) | 2013-01-24 | 2016-09-20 | Ethicon, Inc. | Fibrin sealant compositions with chemical crosslinking |
EP2951193A4 (en) | 2013-02-01 | 2017-03-01 | Children's Medical Center Corporation | Collagen scaffolds |
JP6382854B2 (ja) * | 2013-03-04 | 2018-08-29 | ダーメル,リミティド ライアビリティ カンパニー ディー/ビー/エー エターノジェン,リミティド ライアビリティ カンパニー | InSituで重合する注射可能なコラーゲン組成物 |
US9604184B2 (en) | 2013-03-06 | 2017-03-28 | Orthovita, Inc. | Mixing system and valve assembly |
US9040093B2 (en) | 2013-03-13 | 2015-05-26 | Orthovita, Inc. | Bone graft materials containing calcium phosphate and chitosan |
US10208095B2 (en) | 2013-03-15 | 2019-02-19 | Biomet Manufacturing, Llc | Methods for making cytokine compositions from tissues using non-centrifugal methods |
US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
US9452240B2 (en) | 2013-03-15 | 2016-09-27 | Orthovita, Inc. | Pepsinized collagen implants and biomedical uses thereof |
US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
RU2700162C2 (ru) | 2013-06-21 | 2019-09-13 | Ферросан Медикал Дивайсиз А/С | Расширенная под вакуумом сухая композиция и шприц для ее сохранения |
EP3470094B1 (en) | 2013-12-11 | 2020-07-22 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
FR3014319B1 (fr) * | 2013-12-11 | 2016-12-09 | Nvh Medicinal | Preparations injectables a base de collagenes capables de controler les saignements et/ou de se substituer a des plaquettes dans le cas de syndromes hemorragiques |
US9527244B2 (en) | 2014-02-10 | 2016-12-27 | Global Filtration Systems | Apparatus and method for forming three-dimensional objects from solidifiable paste |
US9550028B2 (en) | 2014-05-06 | 2017-01-24 | Biomet Biologics, LLC. | Single step desiccating bead-in-syringe concentrating device |
CA2960309A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
CN107206165B (zh) | 2014-12-24 | 2020-10-23 | 弗罗桑医疗设备公司 | 用于保持并混合第一和第二物质的注射器 |
US9713810B2 (en) | 2015-03-30 | 2017-07-25 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
US9757721B2 (en) | 2015-05-11 | 2017-09-12 | Biomet Biologics, Llc | Cell washing plunger using centrifugal force |
AU2016290433B2 (en) | 2015-07-03 | 2018-05-24 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
CN105617453A (zh) * | 2016-01-08 | 2016-06-01 | 广州市众为生物技术有限公司 | 一种外科止血生物制品及其使用方法 |
CA3032657A1 (en) | 2016-08-12 | 2018-02-15 | Biom'up | Hemostatic flowable |
US10737479B2 (en) | 2017-01-12 | 2020-08-11 | Global Filtration Systems | Method of making three-dimensional objects using both continuous and discontinuous solidification |
JP2020534267A (ja) | 2017-09-12 | 2020-11-26 | シルパ メディケア リミテッドShilpa Medicare Limited | 膝関節形成のためのトラネキサム酸噴霧 |
KR101989054B1 (ko) | 2017-11-28 | 2019-06-13 | (주)다림티센 | 지혈용 조성물 및 이를 포함하는 용기 |
AU2019221631B2 (en) | 2018-02-15 | 2023-12-07 | Dilon Technologies Inc. | Multi-dimensional hemostatic product and method for producing the same |
WO2019215274A1 (en) | 2018-05-09 | 2019-11-14 | Ferrosan Medical Devices A/S | Method for preparing a haemostatic composition |
US20200000962A1 (en) * | 2018-07-02 | 2020-01-02 | Medtronic Vascular, Inc. | Load bearing crowded collagen constructs |
IL261190A (en) * | 2018-08-16 | 2019-01-31 | Omrix Biopharmaceuticals Ltd | Stable liquid preparations of thrombin |
CN112516377B (zh) * | 2020-11-23 | 2022-05-27 | 铨丰科技(深圳)有限公司 | 一种胶原微纤维止血材料及其制备方法和使用方法 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2433299A (en) * | 1944-01-22 | 1947-12-23 | Parke Davis & Co | Blood coagulant and method of preserving same |
US4215200A (en) * | 1978-10-02 | 1980-07-29 | Cornell Research Foundation, Inc. | Chemically and enzymatically modified collagen hemostatic agent |
AT359652B (de) * | 1979-02-15 | 1980-11-25 | Immuno Ag | Verfahren zur herstellung eines gewebekleb- stoffes |
AT366916B (de) * | 1980-04-02 | 1982-05-25 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes auf basis von menschlichen oder tierischenproteinen |
US4363319A (en) * | 1980-06-30 | 1982-12-14 | Applied Medical Devices, Inc. | Ready-to-use bandage incorporating a coagulant composition and method of preparing same |
US4420339A (en) * | 1981-03-27 | 1983-12-13 | Kureha Kagaku Kogyo Kabushiki Kaisha | Collagen fibers for use in medical treatments |
US4515637A (en) * | 1983-11-16 | 1985-05-07 | Seton Company | Collagen-thrombin compositions |
US4722948A (en) * | 1984-03-16 | 1988-02-02 | Dynatech Corporation | Bone replacement and repair putty material from unsaturated polyester resin and vinyl pyrrolidone |
US4627879A (en) * | 1984-09-07 | 1986-12-09 | The Trustees Of Columbia University In The City Of New York | Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma |
DE3622642A1 (de) * | 1986-07-05 | 1988-01-14 | Behringwerke Ag | Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung |
US5110730A (en) * | 1987-03-31 | 1992-05-05 | The Scripps Research Institute | Human tissue factor related DNA segments |
JPS6440433A (en) * | 1987-08-05 | 1989-02-10 | Green Cross Corp | Aqueous liquid composition of thrombin |
US5290552A (en) * | 1988-05-02 | 1994-03-01 | Matrix Pharmaceutical, Inc./Project Hear | Surgical adhesive material |
EP0341007B1 (en) * | 1988-05-02 | 1994-09-14 | Project Hear | Surgical adhesive material |
US4874368A (en) * | 1988-07-25 | 1989-10-17 | Micromedics, Inc. | Fibrin glue delivery system |
US4902281A (en) * | 1988-08-16 | 1990-02-20 | Corus Medical Corporation | Fibrinogen dispensing kit |
US4891359A (en) * | 1988-12-08 | 1990-01-02 | Johnson & Johnson Patient Care, Inc. | Hemostatic collagen paste composition |
US5226877A (en) * | 1989-06-23 | 1993-07-13 | Epstein Gordon H | Method and apparatus for preparing fibrinogen adhesive from whole blood |
US5077049A (en) * | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
US5218137A (en) * | 1989-08-29 | 1993-06-08 | Duke University | Light activated acyl-enzymes |
US5116315A (en) * | 1989-10-03 | 1992-05-26 | Hemaedics, Inc. | Biological syringe system |
US5318524A (en) * | 1990-01-03 | 1994-06-07 | Cryolife, Inc. | Fibrin sealant delivery kit |
US5219328A (en) * | 1990-01-03 | 1993-06-15 | Cryolife, Inc. | Fibrin sealant delivery method |
DE59005286D1 (de) * | 1990-10-04 | 1994-05-11 | Kallies Import Export Vertrieb | Stabilisiertes Thrombin, seine Herstellung und seine Verwendung als Thrombinzeitreagens. |
CA2097063C (en) * | 1990-11-27 | 2006-08-08 | Howard P. Greisler | Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
SE9101853D0 (sv) * | 1991-06-17 | 1991-06-17 | Jonas Wadstroem | Improved tissue ashesive |
US5254350A (en) * | 1991-07-22 | 1993-10-19 | Helena Laboratories Corporation | Method of preparing a thromboplastin extract |
CA2080428C (en) * | 1991-10-22 | 2004-01-27 | Ray F. Ebert | A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test |
DE4137996A1 (de) * | 1991-11-19 | 1993-05-27 | Behringwerke Ag | Verfahren zur herstellung eines virussicheren thrombinkonzentrates |
US5476777A (en) * | 1991-12-31 | 1995-12-19 | Zymogenetics, Inc. | Methods for producing thrombin |
AU4784693A (en) * | 1992-07-24 | 1994-02-14 | Oklahoma Medical Research Foundation | Blockade of protein c activation reduces microvascular surgical blood loss |
EP0696201B2 (en) * | 1993-03-12 | 2012-09-19 | The American National Red Cross | Supplemented tissue sealants, methods of their production and use |
US5616689A (en) * | 1994-07-13 | 1997-04-01 | Collagen Corporation | Method of controlling structure stability of collagen fibers produced form solutions or dispersions treated with sodium hydroxide for infectious agent deactivation |
US5464471A (en) * | 1994-11-10 | 1995-11-07 | Whalen Biomedical Inc. | Fibrin monomer based tissue adhesive |
JP4223548B2 (ja) * | 1994-12-07 | 2009-02-12 | ジ・アメリカン・ナショナル・レッド・クロス | 補足または非補足組織シーラント、それらの製法および使用 |
US5643192A (en) * | 1995-04-06 | 1997-07-01 | Hamilton Civic Hospitals Research Development, Inc. | Autologous fibrin glue and methods for its preparation and use |
AUPN436995A0 (en) * | 1995-07-24 | 1995-08-17 | Csl Limited | Method for the production of thrombin |
AU7977298A (en) * | 1997-06-18 | 1999-01-04 | Cohesion Technologies, Inc. | Compositions containing thrombin and microfibrillar collagen, and methods for preparation and use thereof |
-
1998
- 1998-06-17 AU AU79772/98A patent/AU7977298A/en not_active Abandoned
- 1998-06-17 CA CA002295247A patent/CA2295247C/en not_active Expired - Fee Related
- 1998-06-17 WO PCT/US1998/012687 patent/WO1998057678A2/en active Application Filing
- 1998-06-17 US US09/099,126 patent/US6096309A/en not_active Expired - Lifetime
- 1998-06-17 EP EP98930365A patent/EP0993311B1/en not_active Expired - Lifetime
- 1998-06-17 JP JP50479199A patent/JP2002514960A/ja not_active Withdrawn
-
1999
- 1999-11-09 US US09/436,903 patent/US6280727B1/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010522617A (ja) * | 2007-03-26 | 2010-07-08 | バクスター・インターナショナル・インコーポレイテッド | 軟部組織増強のための注入可能な空隙の充填剤 |
JP2013508066A (ja) * | 2009-10-23 | 2013-03-07 | セウォン セロンテック カンパニー リミテッド | 血小板豊富血漿(prp)を活性化して組織再生を誘導する組成物及びその製造方法 |
JP2016502448A (ja) * | 2012-12-11 | 2016-01-28 | セウォン セロンテック カンパニー リミテッドSewon Cellontech Co.,Ltd. | コラーゲンとフィブリンとが混合された組織シーラント及びその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
WO1998057678A2 (en) | 1998-12-23 |
CA2295247C (en) | 2009-05-26 |
US6096309A (en) | 2000-08-01 |
EP0993311B1 (en) | 2012-11-14 |
CA2295247A1 (en) | 1998-12-23 |
WO1998057678A3 (en) | 1999-04-01 |
EP0993311A2 (en) | 2000-04-19 |
AU7977298A (en) | 1999-01-04 |
US6280727B1 (en) | 2001-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002514960A (ja) | トロンビンおよびミクロフィブリルコラーゲンを含む組成物、ならびにその調製および使用の方法 | |
US9717820B2 (en) | Procoagulant peptides and their derivatives and uses therefor | |
JP4024302B2 (ja) | 微粒子および創傷治療におけるその用途 | |
US5290552A (en) | Surgical adhesive material | |
US6121232A (en) | Stabilized mixture comprising fibrinogen | |
US4442655A (en) | Fibrinogen-containing dry preparation, manufacture and use thereof | |
US5595735A (en) | Hemostatic thrombin paste composition | |
EP0968008B1 (en) | A stabilized mixture comprising fibrinogen | |
NL192665C (nl) | Weefselkleefstof met een gehalte aan factor XIII en fibrinogeen. | |
JP5268649B2 (ja) | トロンビンを含まない生物学的接着剤及びその医薬としての使用 | |
RU2503464C2 (ru) | Биогель | |
JPH0118055B2 (ja) | ||
US20050118156A1 (en) | Storage-stable fibrin sealant | |
EP1023017A1 (en) | Fibrin glue without fibrinogen and biosealant compositions and methods | |
JPH06508363A (ja) | 組織治療用組成物 | |
JP4932082B2 (ja) | フィブリノーゲンに基づく組織接着剤 | |
CN108463254A (zh) | 密封剂制剂及其用途 | |
CA2253412C (en) | Microparticles and their use in wound therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050614 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090127 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090319 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090511 |
|
A72 | Notification of change in name of applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A721 Effective date: 20090723 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20090723 |